GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
出版年份 2022 全文链接
标题
GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
作者
关键词
-
出版物
Microorganisms
Volume 10, Issue 10, Pages 2061
出版商
MDPI AG
发表日期
2022-10-19
DOI
10.3390/microorganisms10102061
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gut microbiome and health: mechanistic insights
- (2022) Willem M de Vos et al. GUT
- Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study
- (2022) Chih-Yiu Tsai et al. Frontiers in Endocrinology
- Glucagon-like peptide-2 stimulates S-phase entry of intestinal Lgr5+ stem cells
- (2022) Maegan E. Chen et al. Cellular and Molecular Gastroenterology and Hepatology
- The dual GLP‐1 and GLP‐2 receptor agonist dapiglutide promotes barrier function in murine short bowel
- (2022) Johannes Reiner et al. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
- GLP-2 Regulation of Dietary Fat Absorption and Intestinal Chylomicron Production via Neuronal Nitric Oxide Synthase (nNOS) Signaling
- (2022) Elisabeth M. Grande et al. DIABETES
- Short- versus Long-Term, Gender and Species Differences in the Intestinotrophic Effects of Long-Acting Glucagon-Like Peptide 2 Analog
- (2022) P Glerup et al. PHYSIOLOGICAL RESEARCH
- The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
- (2022) Juan Pang et al. Acta Pharmaceutica Sinica B
- Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
- (2022) Jens Juul Holst Frontiers in Nutrition
- The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes
- (2021) Amanda Jacobson et al. Mucosal Immunology
- Neuroprotective Effects of a GLP-2 Analogue in the MPTP Parkinson’s Disease Mouse Model
- (2021) Zijuan Zhang et al. Journal of Parkinsons Disease
- GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological Role
- (2021) Avital Nahmias et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- GLP-2 restores impairments in spatial working memory and hippocampal LTD via the MEK/ERK pathway in juvenile-onset diabetes rats
- (2021) Sachie Sasaki-Hamada et al. BEHAVIOURAL BRAIN RESEARCH
- Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus
- (2021) Junjie Shang et al. PeerJ
- Proglucagon-Derived Peptides as Therapeutics
- (2021) Ryan A. Lafferty et al. Frontiers in Endocrinology
- GLP-1 and Intestinal Diseases
- (2021) Jenna Elizabeth Hunt et al. Biomedicines
- Apraglutide, a novel glucagon‐like peptide‐2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo‐controlled, randomized phase 2 trial
- (2021) Johanna Eliasson et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation
- (2021) Naschla Gasaly et al. Frontiers in Immunology
- Mutational Landscape of the Proglucagon-Derived Peptides
- (2021) Peter Lindquist et al. Frontiers in Endocrinology
- Gut Microbiota and Host Metabolism: From Proof of Concept to Therapeutic Intervention
- (2021) Patrice D. Cani et al. Microorganisms
- Glucagon-Like Peptide-2 Modulates Enteric Paneth Cells Immune Response and Alleviates Gut Inflammation During Intravenous Fluid Infusion in Mice With a Central Catheter
- (2021) Guifang Deng et al. Frontiers in Nutrition
- Expression Profile of the GLP-1 Receptor in the Gastrointestinal Tract and Pancreas in Adult Female Mice
- (2021) Kaare V Grunddal et al. ENDOCRINOLOGY
- Role of the gut microbiome in chronic diseases: a narrative review
- (2021) Amrita Vijay et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Teduglutide in short bowel syndrome patients: A way back to normal life?
- (2021) Felix Harpain et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases
- (2020) Yuhao Jiao et al. Frontiers in Immunology
- The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
- (2020) Ygor Parladore Silva et al. Frontiers in Endocrinology
- Gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice
- (2020) Kunpeng Wu et al. BLOOD
- Interaction between microbiota and immunity in health and disease
- (2020) Danping Zheng et al. CELL RESEARCH
- Mediterranean diet, gut microbiota and health: when age and calories do not add up!
- (2020) Patrice D Cani et al. GUT
- A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
- (2020) Aaron S. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in Medical Nutrition Therapy: Parenteral Nutrition
- (2020) Moran Hellerman Itzhaki et al. Nutrients
- Chinese Propolis Prevents Obesity and Metabolism Syndromes Induced by a High Fat Diet and Accompanied by an Altered Gut Microbiota Structure in Mice
- (2020) Yufei Zheng et al. Nutrients
- The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis
- (2020) Han Xiao et al. Frontiers in Genetics
- Role of Gut Microbiota in Neuroendocrine Regulation of Carbohydrate and Lipid Metabolism via the Microbiota-Gut-Brain-Liver Axis
- (2020) Shu-Zhi Wang et al. Microorganisms
- Glucagon like peptide-2 for Intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans
- (2020) Johana Norona et al. BLOOD
- The pivotal relation between glucagon‐like peptides, NFκB and inflammatory bowel disease
- (2020) Omnia Azmy Nabeh et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion
- (2020) Brandon L. Panaro et al. Molecular Metabolism
- Hematopoietic vs. enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice
- (2020) Elodie M. Varin et al. JCI Insight
- Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity
- (2020) Céline Osinski et al. INTERNATIONAL JOURNAL OF OBESITY
- Glucagon‐like peptide 2 attenuates intestinal mucosal barrier injury through the MLCK/pMLC signaling pathway in a piglet model
- (2020) Yaqi Chang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Gut microbial metabolites as multi-kingdom intermediates
- (2020) Kimberly A. Krautkramer et al. NATURE REVIEWS MICROBIOLOGY
- A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor
- (2020) Wen Sun et al. CELL RESEARCH
- High Fat-High Fructose Diet-Induced Changes in the Gut Microbiota Associated with Dyslipidemia in Syrian Hamsters
- (2020) Rachael G. Horne et al. Nutrients
- Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study
- (2020) Nina L. Hansen et al. Clinical and Translational Gastroenterology
- GLP-2 decreases food intake in the dorsomedial hypothalamic nucleus (DMH) through Exendin (9–39) in male Sprague-Dawley (SD) rats
- (2020) Huiling Sun et al. PHYSIOLOGY & BEHAVIOR
- Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters
- (2019) Lulu Sun et al. Acta Pharmaceutica Sinica B
- Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
- (2019) Mihai Covasa et al. Frontiers in Endocrinology
- Adenosine triphosphate is co-secreted with glucagon-like peptide-1 to modulate intestinal enterocytes and afferent neurons
- (2019) Van B. Lu et al. Nature Communications
- Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments
- (2019) D. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease
- (2019) Shun He et al. NATURE
- The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages
- (2019) Julie Schulthess et al. IMMUNITY
- The role of short-chain fatty acids in microbiota–gut–brain communication
- (2019) Boushra Dalile et al. Nature Reviews Gastroenterology & Hepatology
- Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives
- (2019) Hubert Zatorski et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms
- (2019) Priska Stahel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Microbiomes as sources of emergent host phenotypes
- (2019) J. B. Lynch et al. SCIENCE
- Microbial Control of Intestinal Homeostasis via Enteroendocrine Cell Innate Immune Signaling
- (2019) Paula I. Watnick et al. TRENDS IN MICROBIOLOGY
- Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
- (2019) Mette Simone Aae Madsen et al. Scientific Reports
- The Gut–Liver Axis in the Control of Energy Metabolism and Food Intake in Animals
- (2019) Robert Ringseis et al. Annual Review of Animal Biosciences
- Mechanisms of Parenteral Nutrition-Associated Liver and Gut Injury
- (2019) Himani Madnawat et al. NUTRITION IN CLINICAL PRACTICE
- The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon
- (2018) Charlotte Bayer Christiansen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Oral Bifidobacterium longum expressing GLP-2 improves nutrient assimilation and nutritional homeostasis in mice
- (2018) Qian Zhang et al. JOURNAL OF MICROBIOLOGICAL METHODS
- A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
- (2018) Li Zhao et al. Frontiers in Endocrinology
- Regional variation limits applications of healthy gut microbiome reference ranges and disease models
- (2018) Yan He et al. NATURE MEDICINE
- Effect of Aging and Glucagon-like Peptide 2 on Intestinal Microbiota in SD Rats
- (2018) Jiayu Wu et al. Aging and Disease
- The gut microbiome: Relationships with disease and opportunities for therapy
- (2018) Juliana Durack et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Homeostatic Immunity and the Microbiota
- (2017) Yasmine Belkaid et al. IMMUNITY
- Discovery, characterization, and clinical development of the glucagon-like peptides
- (2017) Daniel J. Drucker et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats
- (2017) Tsukasa Nozu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- GLP-1 nanomedicine alleviates gut inflammation
- (2017) Arivarasu N. Anbazhagan et al. Nanomedicine-Nanotechnology Biology and Medicine
- Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion
- (2017) Lorène J. Lebrun et al. Cell Reports
- Effects of Antidiabetic Drugs on Gut Microbiota Composition
- (2017) et al. Genes
- Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety
- (2017) Lucy Brooks et al. Molecular Metabolism
- The Human Microbiota in Health and Disease
- (2017) Baohong Wang et al. Engineering
- Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages
- (2016) C. Guo et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice
- (2016) Sebastian Steven et al. BRITISH JOURNAL OF PHARMACOLOGY
- Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
- (2016) Ron Sender et al. CELL
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients
- (2016) Mark M. Smits et al. DIABETES OBESITY & METABOLISM
- GLP-1 Induces Barrier Protective Expression in Brunnerʼs Glands and Regulates Colonic Inflammation
- (2016) Claus H. Bang-Berthelsen et al. INFLAMMATORY BOWEL DISEASES
- Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner
- (2016) Łukasz Bułdak et al. Pharmacological Reports
- Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice
- (2016) Tze Guan Tan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
- (2016) Tamara Zietek et al. Frontiers in Immunology
- Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment
- (2016) Lin Wang et al. Scientific Reports
- Central Nervous System Regulation of Intestinal Lipoprotein Metabolism by Glucagon-Like Peptide-1 via a Brain-Gut Axis
- (2015) S. Farr et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix
- (2015) Emma Robinson et al. BASIC RESEARCH IN CARDIOLOGY
- The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease: Figure 1
- (2015) John J Worthington BIOCHEMICAL SOCIETY TRANSACTIONS
- Microbiota and Host Nutrition across Plant and Animal Kingdoms
- (2015) Stéphane Hacquard et al. Cell Host & Microbe
- GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7
- (2015) Jacqueline A. Koehler et al. Cell Metabolism
- GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R
- (2015) Bernardo Yusta et al. DIABETES
- Intake ofLactobacillus reuteriImproves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept
- (2015) Marie-Christine Simon et al. DIABETES CARE
- Glucagon-Like Peptide 2 (GLP-2) Stimulates Postprandial Chylomicron Production and Postabsorptive Release of Intestinal Triglyceride Storage Pools via Induction of Nitric Oxide Signaling in Male Hamsters and Mice
- (2015) Joanne Hsieh et al. ENDOCRINOLOGY
- Gastric emptying and disease activity in inflammatory bowel disease
- (2015) Jutta Keller et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
- (2015) Maria Carlota Dao et al. GUT
- Short-Chain Fatty Acids Regulate Secretion of IL-8 from Human Intestinal Epithelial Cell Linesin vitro
- (2015) M. Asarat et al. IMMUNOLOGICAL INVESTIGATIONS
- Short-chain fatty acids in control of body weight and insulin sensitivity
- (2015) Emanuel E. Canfora et al. Nature Reviews Endocrinology
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
- (2014) Filipe De Vadder et al. CELL
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- GLP-2 Suppresses LPS-Induced Inflammation in Macrophages by Inhibiting ERK Phosphorylation and NF-κB Activation
- (2014) Shanshan Xie et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans
- (2014) C. Xiao et al. DIABETES
- GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6-Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering
- (2014) F. Kahles et al. DIABETES
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Glucagon-Like Peptide-2 Regulates Release of Chylomicrons From the Intestine
- (2014) Satya Dash et al. GASTROENTEROLOGY
- The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents
- (2014) A Psichas et al. INTERNATIONAL JOURNAL OF OBESITY
- Severe Acute Malnutrition in Childhood: Hormonal and Metabolic Status at Presentation, Response to Treatment, and Predictors of Mortality
- (2014) Sarah Bartz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Minireview: Gut Microbiota: The Neglected Endocrine Organ
- (2014) Gerard Clarke et al. MOLECULAR ENDOCRINOLOGY
- Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease
- (2014) Zi-Kai Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Bacterial Metabolite Indole Modulates Incretin Secretion from Intestinal Enteroendocrine L Cells
- (2014) Catalin Chimerel et al. Cell Reports
- Gustducin couples fatty acid receptors to GLP-1 release in colon
- (2013) Yan Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Microbial Modulation of Energy Availability in the Colon Regulates Intestinal Transit
- (2013) Anita Wichmann et al. Cell Host & Microbe
- Intestinal Microbial Diversity during Early-Life Colonization Shapes Long-Term IgE Levels
- (2013) Julia Cahenzli et al. Cell Host & Microbe
- Lipopolysaccharides-Mediated Increase in Glucose-Stimulated Insulin Secretion: Involvement of the GLP-1 Pathway
- (2013) A. T. Nguyen et al. DIABETES
- Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
- (2013) P. Richards et al. DIABETES
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
- (2013) Andrew E. Hogan et al. DIABETOLOGIA
- Beneficial Metabolic Effects of a Probiotic via Butyrate-induced GLP-1 Hormone Secretion
- (2013) Hariom Yadav et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Real-time trafficking and signaling of the glucagon-like peptide-1 receptor
- (2013) Sarah Noerklit Roed et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
- (2013) Yukihiro Furusawa et al. NATURE
- Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor
- (2013) Mamdouh H. Kedees et al. PEPTIDES
- Glucagon-like peptides 1 and 2 in health and disease: A review
- (2013) Chinmay S. Marathe et al. PEPTIDES
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
- (2013) A. Everard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans
- (2012) Changting Xiao et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Transient Inability to Manage Proteobacteria Promotes Chronic Gut Inflammation in TLR5-Deficient Mice
- (2012) Frederic A. Carvalho et al. Cell Host & Microbe
- GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production: Evidence for Predominance of GLP-2-Stimulated Postprandial Lipemia in Normal and Insulin-Resistant States
- (2012) G. J. Hein et al. DIABETES
- Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes
- (2012) Y.-S. Lee et al. DIABETOLOGIA
- Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis
- (2012) Hannelouise Kissow et al. GUT
- Glucagon-Like Peptide-2 (GLP-2) Modulates the cGMP Signalling Pathway by Regulating the Expression of the Soluble Guanylyl Cyclase Receptor Subunits in Cultured Rat Astrocytes
- (2012) Esther Velázquez et al. MOLECULAR NEUROBIOLOGY
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Targeting the glucagon receptor family for diabetes and obesity therapy
- (2012) Young Min Cho et al. PHARMACOLOGY & THERAPEUTICS
- Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice
- (2012) Hannelouise Kissow et al. REGULATORY PEPTIDES
- Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function
- (2012) T. Olszak et al. SCIENCE
- Interactions Between the Microbiota and the Immune System
- (2012) L. V. Hooper et al. SCIENCE
- Inside the Mucosal Immune System
- (2012) Jerry R. McGhee et al. PLOS BIOLOGY
- Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
- (2012) Xochitl C Morgan et al. GENOME BIOLOGY
- Dysregulation of Allergic Airway Inflammation in the Absence of Microbial Colonization
- (2011) Tina Herbst et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease
- (2011) Alan W Walker et al. BMC MICROBIOLOGY
- Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2
- (2011) G. Tolhurst et al. DIABETES
- Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes
- (2011) A. J. Tremblay et al. DIABETES OBESITY & METABOLISM
- Effect of Exenatide on Inflammatory and Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus
- (2011) Jin-dan Wu et al. Diabetes Technology & Therapeutics
- Epithelial barrier biology: good fences make good neighbours
- (2011) Emmanuelle Moens et al. IMMUNOLOGY
- Exenatide Exerts a Potent Antiinflammatory Effect
- (2011) Ajay Chaudhuri et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific
- (2011) Julia Benckert et al. JOURNAL OF CLINICAL INVESTIGATION
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis
- (2011) Charles L. Bevins et al. NATURE REVIEWS MICROBIOLOGY
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- A human gut microbial gene catalogue established by metagenomic sequencing
- (2010) Junjie Qin et al. NATURE
- Epithelial crosstalk at the microbiota-mucosal interface
- (2010) J. M. Wells et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
- (2010) M. Vijay-Kumar et al. SCIENCE
- Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses
- (2010) S. Hapfelmeier et al. SCIENCE
- GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons
- (2009) Yi Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
- (2009) J. Hsieh et al. DIABETOLOGIA
- Glucagon-Like Peptide-2 Increases Intestinal Lipid Absorption and Chylomicron Production via CD36
- (2009) Joanne Hsieh et al. GASTROENTEROLOGY
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
- (2009) P. D. Cani et al. GUT
- Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs disease
- (2009) Alan L. Buchman et al. INFLAMMATORY BOWEL DISEASES
- The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation
- (2009) T. Bansal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GLP-1: Broadening the incretin concept to involve gut motility
- (2009) Per M. Hellström REGULATORY PEPTIDES
- Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut Microbiome
- (2008) Peter J. Turnbaugh et al. Cell Host & Microbe
- Butyrate and trichostatin A attenuate nuclear factor κB activation and tumor necrosis factor α secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells
- (2008) Makoto Usami et al. NUTRITION RESEARCH
- Glucagon-like peptide-2 increases mesenteric blood flow in humans
- (2008) Lasse Bremholm et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started